Search

Search bills, members, committees and pages...

ACESSO BIOLOGICS

7 federal lobbying filings, 2025 to 2026.

ACESSO BIOLOGICS is a client on 7 federal lobbying filings, 2025 to 2026, reporting $310K across them. Biologics Company Based in Nevada.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

1 it has hired, by filings.

RegistrantFilingsReported
THE MCMANUS GROUP7$310K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$120K
20255$190K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
MMMMedicare/Medicaid6
HCRHealth Issues1

Bills

The bills the filings name, by how many name them.

BillTitleFilings
S. 2561Skin Substitute Access and Payment Reform Act of 20254
H.R. 5768Skin Substitute Access and Payment Reform Act3
H.R. 6852Advanced Wound Care and Regenerative Medicine Access and Reform Act3

Lobbyists

Named on the filings.

LobbyistClientsFilings
ALEX WHALEN17
JOHN MCMANUS17

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
ACESSO BIOLOGICSTHE MCMANUS GROUP2026 second_quarter$60KJul 20, 2026
ACESSO BIOLOGICSTHE MCMANUS GROUP2026 first_quarter$60KApr 20, 2026
ACESSO BIOLOGICSTHE MCMANUS GROUP2025 fourth_quarter$60KJan 20, 2026
ACESSO BIOLOGICSTHE MCMANUS GROUP2025 third_quarter$50KOct 20, 2025
ACESSO BIOLOGICSTHE MCMANUS GROUP2025 second_quarter$50KAug 4, 2025
ACESSO BIOLOGICSTHE MCMANUS GROUP2025 first_quarter$30KApr 21, 2025
ACESSO BIOLOGICSTHE MCMANUS GROUP2025 first_quarterFeb 21, 2025